University hospital-based drug information service in a developing country M. P. Joshi SPECIAL ARTICLE Pages: 89 - 94
Twenty-four-hour blood pressure monitoring during treatment with extended-release felodipine versus slow-release nifedipine in elderly patients with mild to moderate hypertension: a randomized, double-blind, cross-over study D. BonaduceV. CanonicoF. Rengo PHARMACODYNAMICS Pages: 95 - 100
Povidone-iodine wash solutions in the prevention of superficial fungal infections; predictive evaluation using the corneofungimetry bioassay G. E. PiérardC. Piérard-FranchimontJ. E. Arrese PHARMACODYNAMICS Pages: 101 - 104
Drug-induced chest pain and myocardial infarction. Reports to a national centre and review of the literature J. P. OttervangerJ. H. P. WilsonB. H. C. Stricker PHARMACOEPIDEMIOLOGY AND PRESCRIPTION Pages: 105 - 110
Pharmacokinetics of mezlocillin and sulbactam under continuous veno-venous hemodialysis (CVVHD) in intensive care patients with acute renal failure B. RohdeU. WernerB. Drewelow PHARMACOKINETICS AND DISPOSITION Pages: 111 - 115
The pharmacokinetics of pravastatin in patients on chronic hemodialysis T. W. B. GehrD. A. SicaN. F. Ford PHARMACOKINETICS AND DISPOSITION Pages: 117 - 121
Clearance of ceftriaxone during haemodialysis using cuprophane, haemophane and polysulfone dialysers L. GabuttiL. Taminelli-BeltraminelliC. Marone PHARMACOKINETICS AND DISPOSITION Pages: 123 - 126
Comparative pharmacokinetics of dirithromycin and erythromycin in normal volunteers with special regard to accumulation in polymorphonuclear leukocytes and in saliva H. F. Geerdes-FengeB. GoetschiH. Lode PHARMACOKINETICS AND DISPOSITION Pages: 127 - 133
Food increases the bioavailability of mefloquine C. CrevoisierJ. HandschinC. Kleinbloesem PHARMACOKINETICS AND DISPOSITION Pages: 135 - 139
The influence of two types of meal on the pharmacokinetics of a modified-release formulation of nifedipine (Adalat Retard) J. ArmstrongV. F. ChallenorD. G. Waller PHARMACOKINETICS AND DISPOSITION Pages: 141 - 143
The effect of codeine on gastrointestinal transit in extensive and poor metabolisers of debrisoquine J. HasselströmQ. Y. YueJ. Säwe PHARMACOKINETICS AND DISPOSITION Pages: 145 - 148
Concomitant administration of the α-glucosidase inhibitor voglibose (AO-128) does not alter the pharmacokinetics of glibenclamide P. KleistA. EhrlichH. Fuder PHARMACOKINETICS AND DISPOSITION Pages: 149 - 152
The α-glucosidase inhibitor voglibose (AO-128) does not change pharmacodynamics or pharmacokinetics of warfarin H. FuderP. KleistP. W. Lücker PHARMACOKINETICS AND DISPOSITION Pages: 153 - 157